Skin Replacements and Substitutes | Market Insights | US | 2022
The COVID-19 pandemic resulted in reduced procedure volumes, negatively impacting the US market for skin replacements and substitutes in the short term. However, after a period of recovery, favorable demographics and the adoption of new innovative products will continue to drive moderate revenue growth in both the biologic and biosynthetic market segments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for skin replacements and substitutes in the US across an 11-year period.